chr15-74411888-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_003612.5(SEMA7A):āc.1419G>Cā(p.Glu473Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_003612.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEMA7A | NM_003612.5 | c.1419G>C | p.Glu473Asp | missense_variant | 11/14 | ENST00000261918.9 | |
SEMA7A | NM_001146029.3 | c.1377G>C | p.Glu459Asp | missense_variant | 10/13 | ||
SEMA7A | NM_001146030.3 | c.924G>C | p.Glu308Asp | missense_variant | 11/14 | ||
SEMA7A | XM_047433177.1 | c.1296G>C | p.Glu432Asp | missense_variant | 11/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEMA7A | ENST00000261918.9 | c.1419G>C | p.Glu473Asp | missense_variant | 11/14 | 1 | NM_003612.5 | P1 | |
SEMA7A | ENST00000543145.6 | c.1377G>C | p.Glu459Asp | missense_variant | 10/13 | 2 | |||
SEMA7A | ENST00000542748.6 | c.924G>C | p.Glu308Asp | missense_variant | 11/14 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250814Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135662
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461502Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727050
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at